Software - Application
Compare Stocks
5 / 10Stock Comparison
SURG vs SSTK vs ADBE vs LQDT vs AMZN
Revenue, margins, valuation, and 5-year total return — side by side.
Internet Content & Information
Software - Infrastructure
Specialty Retail
Specialty Retail
SURG vs SSTK vs ADBE vs LQDT vs AMZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Internet Content & Information | Software - Infrastructure | Specialty Retail | Specialty Retail |
| Market Cap | $11M | $624M | $105.94B | $1.12B | $2.92T |
| Revenue (TTM) | $50M | $946M | $24.45B | $480M | $742.78B |
| Net Income (TTM) | $-42M | $-21M | $7.21B | $30M | $90.80B |
| Gross Margin | -38.6% | 57.5% | 89.2% | 23.2% | 50.6% |
| Operating Margin | -78.8% | 3.9% | 36.8% | 8.4% | 11.5% |
| Forward P/E | — | 13.6x | 10.9x | 24.3x | 34.8x |
| Total Debt | $5M | $318M | $6.65B | $14M | $152.99B |
| Cash & Equiv. | $12M | $178M | $5.43B | $175M | $86.81B |
SURG vs SSTK vs ADBE vs LQDT vs AMZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SurgePays, Inc. (SURG) | 100 | 3.6 | -96.4% |
| Shutterstock, Inc. (SSTK) | 100 | 44.8 | -55.2% |
| Adobe Inc. (ADBE) | 100 | 66.4 | -33.6% |
| Liquidity Services,… (LQDT) | 100 | 634.9 | +534.9% |
| Amazon.com, Inc. (AMZN) | 100 | 222.1 | +122.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SURG vs SSTK vs ADBE vs LQDT vs AMZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, SURG doesn't own a clear edge in any measured category.
SSTK is the #2 pick in this set and the best alternative if dividends is your priority.
- 7.6% yield; 5-year raise streak; the other 4 pay no meaningful dividend
ADBE carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 1.20 vs AMZN's 1.24
- Lower P/E (10.9x vs 34.8x), PEG 1.20 vs 1.24
- 29.5% margin vs SURG's -83.4%
- Beta 0.74 vs AMZN's 1.51
LQDT ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.76
- Rev growth 31.2%, EPS growth 38.1%, 3Y rev CAGR 19.4%
- Lower volatility, beta 0.76, Low D/E 6.9%, current ratio 1.38x
- Beta 0.76, current ratio 1.38x
AMZN is the clearest fit if your priority is long-term compounding.
- 7.0% 10Y total return vs LQDT's 5.1%
- +43.7% vs SURG's -78.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.2% revenue growth vs SURG's -55.6% | |
| Value | Lower P/E (10.9x vs 34.8x), PEG 1.20 vs 1.24 | |
| Quality / Margins | 29.5% margin vs SURG's -83.4% | |
| Stability / Safety | Beta 0.74 vs AMZN's 1.51 | |
| Dividends | 7.6% yield; 5-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +43.7% vs SURG's -78.9% | |
| Efficiency (ROA) | 24.8% ROA vs SURG's -242.4%, ROIC 51.4% vs -229.7% |
SURG vs SSTK vs ADBE vs LQDT vs AMZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SURG vs SSTK vs ADBE vs LQDT vs AMZN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ADBE leads in 2 of 6 categories
SURG leads 1 • SSTK leads 1 • LQDT leads 0 • AMZN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ADBE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 14745.6x SURG's $50M. ADBE is the more profitable business, keeping 29.5% of every revenue dollar as net income compared to SURG's -83.4%. On growth, SURG holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $50M | $946M | $24.5B | $480M | $742.8B |
| EBITDAEarnings before interest/tax | -$39M | $118M | $9.6B | $51M | $155.9B |
| Net IncomeAfter-tax profit | -$42M | -$21M | $7.2B | $30M | $90.8B |
| Free Cash FlowCash after capex | -$26M | $114M | $10.3B | $78M | -$2.5B |
| Gross MarginGross profit ÷ Revenue | -38.6% | +57.5% | +89.2% | +23.2% | +50.6% |
| Operating MarginEBIT ÷ Revenue | -78.8% | +3.9% | +36.8% | +8.4% | +11.5% |
| Net MarginNet income ÷ Revenue | -83.4% | -2.2% | +29.5% | +6.3% | +12.2% |
| FCF MarginFCF ÷ Revenue | -50.9% | +12.0% | +42.2% | +16.2% | -0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | -17.9% | +12.0% | +3.7% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +47.2% | -3.5% | +11.4% | +4.5% | +74.8% |
Valuation Metrics
SURG leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 13.6x trailing earnings, SSTK trades at a 67% valuation discount to LQDT's 41.7x P/E. Adjusting for growth (PEG ratio), AMZN offers better value at 1.35x vs ADBE's 1.70x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $624M | $105.9B | $1.1B | $2.92T |
| Enterprise ValueMkt cap + debt − cash | $4M | $763M | $107.2B | $964M | $2.98T |
| Trailing P/EPrice ÷ TTM EPS | -0.23x | 13.59x | 15.36x | 41.67x | 37.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 10.90x | 24.33x | 34.77x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.70x | — | 1.35x |
| EV / EBITDAEnterprise value multiple | — | 3.80x | 11.25x | 21.19x | 20.47x |
| Price / SalesMarket cap ÷ Revenue | 0.18x | 0.63x | 4.46x | 2.36x | 4.07x |
| Price / BookPrice ÷ Book value/share | 0.70x | 1.06x | 9.42x | 5.78x | 7.14x |
| Price / FCFMarket cap ÷ FCF | — | 5.04x | 10.75x | 19.07x | 378.98x |
Profitability & Efficiency
ADBE leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ADBE delivers a 62.3% return on equity — every $100 of shareholder capital generates $62 in annual profit, vs $-10 for SURG. LQDT carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to ADBE's 0.57x. On the Piotroski fundamental quality scale (0–9), SSTK scores 8/9 vs SURG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | -3.6% | +62.3% | +14.2% | +23.3% |
| ROA (TTM)Return on assets | -2.4% | -1.5% | +24.8% | +8.0% | +11.5% |
| ROICReturn on invested capital | -2.3% | +11.5% | +51.4% | +60.8% | +14.7% |
| ROCEReturn on capital employed | -177.3% | +15.6% | +44.6% | +17.3% | +15.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 8 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.30x | 0.55x | 0.57x | 0.07x | 0.37x |
| Net DebtTotal debt minus cash | -$7M | $139M | $1.2B | -$160M | $66.2B |
| Cash & Equiv.Liquid assets | $12M | $178M | $5.4B | $175M | $86.8B |
| Total DebtShort + long-term debt | $5M | $318M | $6.6B | $14M | $153.0B |
| Interest CoverageEBIT ÷ Interest expense | -40.65x | 1.71x | 66.23x | — | 39.96x |
Total Returns (Dividends Reinvested)
Evenly matched — LQDT and AMZN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMZN five years ago would be worth $16,476 today (with dividends reinvested), compared to $715 for SURG. Over the past 12 months, AMZN leads with a +43.7% total return vs SURG's -78.9%. The 3-year compound annual growth rate (CAGR) favors LQDT at 37.0% vs SURG's -49.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.4% | -7.2% | -23.0% | +22.5% | +19.7% |
| 1-Year ReturnPast 12 months | -78.9% | +5.7% | -33.4% | +15.0% | +43.7% |
| 3-Year ReturnCumulative with dividends | -86.9% | -61.2% | -25.4% | +157.1% | +156.2% |
| 5-Year ReturnCumulative with dividends | -92.8% | -73.5% | -47.5% | +47.8% | +64.8% |
| 10-Year ReturnCumulative with dividends | -99.1% | -34.5% | +171.1% | +508.2% | +697.8% |
| CAGR (3Y)Annualised 3-year return | -49.3% | -27.1% | -9.3% | +37.0% | +36.8% |
Risk & Volatility
Evenly matched — ADBE and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
ADBE is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than AMZN's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs SURG's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 1.48x | 0.74x | 0.76x | 1.51x |
| 52-Week HighHighest price in past year | $3.45 | $29.50 | $422.95 | $38.83 | $278.56 |
| 52-Week LowLowest price in past year | $0.46 | $14.73 | $224.18 | $21.67 | $185.01 |
| % of 52W HighCurrent price vs 52-week peak | +16.2% | +57.6% | +60.6% | +93.4% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 39.9 | 44.0 | 52.2 | 81.6 | 81.1 |
| Avg Volume (50D)Average daily shares traded | 378K | 265K | 5.5M | 159K | 45.5M |
Analyst Outlook
SSTK leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SSTK as "Hold", ADBE as "Buy", LQDT as "Buy", AMZN as "Buy". Consensus price targets imply 294.5% upside for SSTK (target: $67) vs 13.1% for AMZN (target: $307). SSTK is the only dividend payer here at 7.55% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $67.00 | $345.50 | $44.00 | $306.77 |
| # AnalystsCovering analysts | — | 18 | 62 | 14 | 94 |
| Dividend YieldAnnual dividend ÷ price | — | +7.6% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 5 | 0 | 1 | — |
| Dividend / ShareAnnual DPS | — | $1.28 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | 0.0% | +10.6% | +1.4% | 0.0% |
ADBE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SURG leads in 1 (Valuation Metrics). 2 tied.
SURG vs SSTK vs ADBE vs LQDT vs AMZN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SURG or SSTK or ADBE or LQDT or AMZN a better buy right now?
For growth investors, Liquidity Services, Inc.
(LQDT) is the stronger pick with 31. 2% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). Shutterstock, Inc. (SSTK) offers the better valuation at 13. 6x trailing P/E, making it the more compelling value choice. Analysts rate Adobe Inc. (ADBE) a "Buy" — based on 62 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SURG or SSTK or ADBE or LQDT or AMZN?
On trailing P/E, Shutterstock, Inc.
(SSTK) is the cheapest at 13. 6x versus Liquidity Services, Inc. at 41. 7x. On forward P/E, Adobe Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Adobe Inc. wins at 1. 20x versus Amazon. com, Inc. 's 1. 24x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SURG or SSTK or ADBE or LQDT or AMZN?
Over the past 5 years, Amazon.
com, Inc. (AMZN) delivered a total return of +64. 8%, compared to -92. 8% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: AMZN returned +697. 8% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SURG or SSTK or ADBE or LQDT or AMZN?
By beta (market sensitivity over 5 years), Adobe Inc.
(ADBE) is the lower-risk stock at 0. 74β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately 104% more volatile than ADBE relative to the S&P 500. On balance sheet safety, Liquidity Services, Inc. (LQDT) carries a lower debt/equity ratio of 7% versus 57% for Adobe Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SURG or SSTK or ADBE or LQDT or AMZN?
By revenue growth (latest reported year), Liquidity Services, Inc.
(LQDT) is pulling ahead at 31. 2% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: Liquidity Services, Inc. grew EPS 38. 1% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, LQDT leads at 19. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SURG or SSTK or ADBE or LQDT or AMZN?
Adobe Inc.
(ADBE) is the more profitable company, earning 30. 0% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps 30. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADBE leads at 36. 6% versus -68. 6% for SURG. At the gross margin level — before operating expenses — ADBE leads at 88. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SURG or SSTK or ADBE or LQDT or AMZN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Adobe Inc. (ADBE) is the more undervalued stock at a PEG of 1. 20x versus Amazon. com, Inc. 's 1. 24x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Adobe Inc. (ADBE) trades at 10. 9x forward P/E versus 34. 8x for Amazon. com, Inc. — 23. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SSTK: 294. 5% to $67. 00.
08Which pays a better dividend — SURG or SSTK or ADBE or LQDT or AMZN?
In this comparison, SSTK (7.
6% yield) pays a dividend. SURG, ADBE, LQDT, AMZN do not pay a meaningful dividend and should not be held primarily for income.
09Is SURG or SSTK or ADBE or LQDT or AMZN better for a retirement portfolio?
For long-horizon retirement investors, Liquidity Services, Inc.
(LQDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76), +508. 2% 10Y return). Both have compounded well over 10 years (LQDT: +508. 2%, SURG: -99. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SURG and SSTK and ADBE and LQDT and AMZN?
These companies operate in different sectors (SURG (Technology) and SSTK (Communication Services) and ADBE (Technology) and LQDT (Consumer Cyclical) and AMZN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SURG is a small-cap quality compounder stock; SSTK is a small-cap deep-value stock; ADBE is a mid-cap deep-value stock; LQDT is a small-cap high-growth stock; AMZN is a mega-cap quality compounder stock. SSTK pays a dividend while SURG, ADBE, LQDT, AMZN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Gross Margin > 34%
- Dividend Yield > 3.0%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.